NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.
Li Qin,Ye-Lin Wu,Michael J Toneff,Dabing Li,Lan Liao,Xiuhua Gao,Fiona T Bane,Jean C-Y Tien,Yixiang Xu,Zhen Feng,Zhihui Yang,Yan Xu,Sarah M Theissen,Yi Li,Leonie Young,Jianming Xu
DOI: https://doi.org/10.1158/0008-5472.can-13-2639
IF: 11.2
2014-01-01
Cancer Research
Abstract:In breast cancer, overexpression of the nuclear coactivator NCOA1 (SRC-1) is associated with disease recurrence and resistance to endocrine therapy. To examine the impact of NCOA1 overexpression on morphogenesis and carcinogenesis in the mammary gland (MG), we generated MMTV-hNCOA1 transgenic [Tg(NCOA1)] mice. In the context of two distinct transgenic models of breast cancer, NCOA1 overexpression did not affect the morphology or tumor-forming capability of MG epithelial cells. However, NCOA1 overexpression increased the number of circulating breast cancer cells and the efficiency of lung metastasis. Mechanistic investigations showed that NCOA1 and c-Fos were recruited to a functional AP-1 site in the macrophage attractant CSF1 promoter, directly upregulating colony-simulating factor 1 (CSF1) expression to enhance macrophage recruitment and metastasis. Conversely, silencing NCOA1 reduced CSF1 expression and decreased macrophage recruitment and breast cancer cell metastasis. In a cohort of 453 human breast tumors, NCOA1 and CSF1 levels correlated positively with disease recurrence, higher tumor grade, and poor prognosis. Together, our results define an NCOA1/AP-1/CSF1 regulatory axis that promotes breast cancer metastasis, offering a novel therapeutic target for impeding this process.